SIADH in Systemic JIA Resolving After Treatment With an IL-6 Inhibitor
2018
Interleukin-6 (IL-6) is implicated in the pathogenesis of both systemic juvenile idiopathic arthritis (SJIA) and syndrome of inappropriate secretion of
antidiuretichormone (SIADH), but the 2 have not been previously described as occurring together. We report a case of a 6-year-old girl with symptoms of arthralgia, daily fevers, evanescent rash, lymphadenopathy, and laboratory evaluation showing elevated inflammatory markers, consistent with SJIA. At presentation, the patient had
hyponatremiawith a sodium level of 128 mEq/L. She had low
serum osmolalitywith elevated
urine osmolality, consistent with SIADH.
Hyponatremiaimproved temporarily during times of fluid restriction as expected in SIADH, but did not resolve until SJIA was treated successfully with
tocilizumab, an IL-6 receptor antibody that inhibits IL-6 activity. The positive response to treatment with
tocilizumabsupports the role of IL-6 in the pathogenesis of both SJIA and SIADH. Patients with SJIA should be monitored for SIADH to avoid complications of untreated
hyponatremia.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
17
References
10
Citations
NaN
KQI